Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
To observe the long-term efficacy and safety of autologous non cultured epidermal cell suspension transplantation in the treatment of vitiligo, analyze the correlation between cell density, type, and postoperative efficacy and prognosis, and providing a basis for clinical application.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 8
Maximum Age: 65
Healthy Volunteers: f
View:
• Patients diagnosed as vitiligo, according to the Vitiligo Diagnosis and Treatment Consensus (2021 edition)
• Segmental and unclassified vitiligo stable for 6 months, Non-segmental vitiligo stable for 1 year and resistant to medication and phototherapy
• BSA≥5%
• Sign the informed consent and be willing to undergo surgical treatment
• 8-65 years old, both genders
Locations
Other Locations
China
Peking University People's Hospital
RECRUITING
Beijing
Time Frame
Start Date: 2024-04-25
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 30
Treatments
Experimental: NCES
Related Therapeutic Areas
Sponsors
Leads: Peking University People's Hospital